Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gordon J. Freeman is active.

Publication


Featured researches published by Gordon J. Freeman.


Archive | 2000

Adhesion and Costimulatory Molecules

Vassiliki A. Boussiotis; Gordon J. Freeman; Lee M. Nadler

For successful immune activation, T-cells require two signals. The first signal confers specificity and is mediated by the T-cell receptor (TCR). The second signal, costimulation, is delivered by accessory cell-surface molecules expressed on antigenpresenting cells (APCs). In the absence of costimulation, T-cells enter a state of unresponsiveness termed anergy in vitro and tolerance in vivo (1,2). Anergy reflects the inability of antigen-specific T-cells stimulated through their antigen receptor to mount a secondary antigen-specific response on rechallenge. Tolerance is the identical response reflected in the inability of the intact host to mount an effective secondary antigen-specific response in vivo. Induction of anergy is a dynamic process during which T-cells remain alive yet unreactive toward antigens. T-cell tolerance is defined as the inability of an organism to distinguish foreign from self and can be the result of either deletion or inactivation of the antigen-specific T-cells. Tolerance in the thymus is largely a result of clonal deletion. However, recent studies have demonstrated that T-cell inactivation or anergy is a major mechanism of subsequent tolerance in the peripheral lymphoid tissue.


International Immunology | 1995

Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion

Yuji Ueda; Bruce L. Levine; Mark L. Huang; Gordon J. Freeman; Lee M. Nadler; Carl H. June; Stephen G. Ward


Archive | 1994

Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies

John G. Gribben; Gordon J. Freeman; Lee M. Nadler; Paul D. Rennert; Cindy L. Jellis; Edward A. Greenfield; Gary S. Gray


Archive | 2017

MOLÉCULAS DE ANTICUERPO QUE SE UNEN A PD-L1 Y SUS USOS

Glenn Dranoff; Jennifer Marie Mataraza; Hwai Wen Chang; Gerhard Johann Frey; Arlene H. Sharpe; Gordon J. Freeman


Archive | 2017

MOLÉCULAS DE ANTICUERPO QUE SE UNEN A LAG-3 Y USOS DE LAS MISMAS

Fangmin Xu; John Taraszka; Tiancen Hu; Gordon J. Freeman; Dale T. Umetsu; Rosemarie H Dkruyff; Maximiliano Vasquez; Daniel J. Hicklin; Walter A. Blattler; Catherine Anne Sabatos Peyton; Jennifer Marie Mataraza; Thomas Pietzonka; Thomas Huber; Alan S. Harris; Barbara Brannetti


Archive | 2017

Anticuerpo moléculas de tim-3 y usos de los mismos

Catherine Anne Sabatos-Peyton; Barbara Brannetti; Alan S. Harris; Thomas Huber; Thomas Pietzonka; Jennifer Marie Mataraza; Walter A. Blattler; Daniel J. Hicklin; Maximiliano Vasquez; Rosemarie H. Dekruyff; Dale T. Umetsu; Gordon J. Freeman; Tiancen Hu; John Taraszka; Fangmin Xu


Archive | 2016

Regulatory t cell pd-1 modulation for regulating t cell effector immune responses

Arlene H. Sharpe; Gordon J. Freeman; Loise M. Francisco; Peter T. Sage; Sun J. Lee; Scott B. Lovitch; Vikram R. Juneja; Catherine L. Tan


Archive | 2016

Anti-Programmed Death 1 (PD1)

Gordon J. Freeman; Arlene H. Sharpe


Archive | 2016

Methods of reducing liver pd-1-expressing cd8+t cells using pd-1 fc fusion proteins that bind fc receptors

Gordon J. Freeman; Rafi Ahmed; Arlene H. Sharpe; Masao Hashimoto; Hyun Tak Jin


Archive | 2016

Polythérapies comprenant des molécules d'anticorps contre tim -3

Glenn Dranoff; Catherine Anne Sabatos-Peyton; Barbara Brannetti; Alan S. Harris; Thomas Huber; Thomas Pietzonka; Jennifer Marie Mataraza; Walter A. Blattler; Daniel J. Hicklin; Maximiliano Vasquez; Rosemarie H. Dekruyff; Dale T. Umetsu; Gordon J. Freeman; Tiancen Hu; John Taraszka; Fangmin Xu

Collaboration


Dive into the Gordon J. Freeman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge